0

ICI 192605

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP117621644
CAS117621-64-4
Structure
MDL NumberMFCD00673936
Molecular Weight402.87
InChI KeyWHUIENZXNGAHQI-YGPRPMEGSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥20 mg/mL
Assay≥98% (HPLC)
Colorwhite to tan
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Effects of a Thromboxane Receptor Antagonist on Prostaglandin D2 and Histamine Induced Bronchoconstriction in Man

N al Jarad, K P Hui, N Barnes

Br J Clin Pharmacol. 1994 Jan;37(1):97-100.

PMID: 8148229

1

Endothelium-dependent Vasorelaxation Induced by L-carnitine in Isolated Aorta From Normotensive and Hypertensive Rats

María Dolores Herrera, Rosario Bueno, María Alvarez De Sotomayor, Concepción Pérez-Guerrero, Carmen M Vázquez, Elisa Marhuenda

J Pharm Pharmacol. 2002 Oct;54(10):1423-7.

PMID: 12396307

1

Improved Synthetic Routes to the Novel Thromboxane Receptor Antagonist ICI 192605: Activity of Synthetic 1,3-dioxane Intermediates

G R Brown, A J Foubister, J A Hudson

J Pharm Pharmacol. 1990 Jan;42(1):53-5.

PMID: 1969951

1

Involvement of TP and EP3 Receptors in Vasoconstrictor Responses to Isoprostanes in Pulmonary Vasculature

Luke J Janssen, Tracy Tazzeo

J Pharmacol Exp Ther. 2002 Jun;301(3):1060-6.

PMID: 12023538

1

Platelet Reactivity in Vitro in Relation to Thromboxane in Healthy Pregnancy

E H Horn, E Hardy, J Cooper, S Heptinstall, P C Rubin

Thromb Haemost. 1996 Feb;75(2):346-51.

PMID: 8815588

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode